Details of Disease

General Information of Disease (ID: DIS0DAK3)

Disease Name Gastric neuroendocrine tumor, well differentiated, low or intermediate grade
Synonyms
well-differentiated neuroendocrine tumours of the stomach; well-differentiated neuroendocrine tumors of the stomach; gastric well differentiated endocrine tumor/carcinoma; gastric NET; GNET; gastric neuroendocrine tumor; gastric well differentiated endocrine tumor; gastric neuroendocrine tumour; gastric NET G1/2; gastric well differentiated endocrine tumour
Definition A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the stomach.
Disease Hierarchy
DISQBSKS: Gastric neuroendocrine neoplasm
DISNPLOO: Neuroendocrine neoplasm
DISDR98B: Digestive system neuroendocrine tumor, grade 1/2
DIS0DAK3: Gastric neuroendocrine tumor, well differentiated, low or intermediate grade
Disease Identifiers
MONDO ID
MONDO_0015062
UMLS CUI
C3272399
MedGen ID
474032

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
CCKBR TTVFO0U Definitive Biomarker [1]
------------------------------------------------------------------------------------

References

1 Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.Br J Clin Pharmacol. 2017 Mar;83(3):466-475. doi: 10.1111/bcp.13146. Epub 2016 Nov 21.